Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_assertion description "[These results strongly support the utilization of PI3K pathway inhibitors in ovarian cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_assertion evidence source_evidence_literature NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_assertion SIO_000772 21563232 NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_assertion wasDerivedFrom befree-20140225 NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_assertion wasGeneratedBy ECO_0000203 NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP621710.RAkDl0tMBmk7vAFVi9KZrrv0Swy0qMKksTv-H6WlkQTJI130_provenance.